A phase II single arm multi-center trial evaluating the efficacy of pembrolizumab in the treatment of patients with incurable platinum refractory germ cell tumors.

For full description, see www.clinicaltrials.gov.

Manuscripts/Articles:

• N Adra, LH Einhorn, SK Althouse, NR Ammakkanavar, D Musapatika, C Albany, D Vaughn, NH Hanna. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206. Annals of Oncology 29: 209–214, 2018. doi:10.1093/annonc/mdx680. Published online 17 October 2017. See abstract.

Abstracts/Posters/Presentations:

• N Adra, N Ammakkanavar, M Radovich, DJ Vaughn, C Albany, LH Einhorn, NH Hanna. A phase II single arm multi-center trial evaluating the efficacy of pembrolizumab in the treatment of patients (pts) with incurable platinum refractory germ cell tumors (GCT). Accepted as a trials in progress poster session at the ASCO Annual Meeting, June 3-7, 2016, Chicago IL. J Clin Oncol 34, 2016 (suppl; abstr TPS4579). See abstract.